[SDG] QoQ TTM Result on 31-Dec-2019 [#4]

Stock
[SDG] SD GUTHRIE BERHAD
Announcement Date
28-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -66.41%
YoY- -83.17%
Quarter Report
Latest QR
Upcoming QR
SDG's Result
SDG's Financial Summary
View:
Show?
TTM Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 12,818,000 12,457,000 12,116,000 12,078,000 12,206,000 12,424,000 12,633,000 0.97%
PBT 1,469,000 1,242,000 699,000 217,000 430,000 558,000 731,000 59.04%
Tax -333,000 -545,000 -356,000 -264,000 -303,000 -76,000 -244,000 22.96%
NP 1,136,000 697,000 343,000 -47,000 127,000 482,000 487,000 75.61%
-
NP to SH 917,000 759,000 408,000 88,000 262,000 345,000 348,000 90.44%
-
Tax Rate 22.67% 43.88% 50.93% 121.66% 70.47% 13.62% 33.38% -
Total Cost 11,682,000 11,760,000 11,773,000 12,125,000 12,079,000 11,942,000 12,146,000 -2.55%
-
Net Worth 13,562,613 14,113,379 13,218,384 13,287,229 13,424,922 13,631,459 13,631,459 -0.33%
Dividend
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Div 276,759 276,759 - - 115,617 115,617 1,067,757 -59.24%
Div Payout % 30.18% 36.46% - - 44.13% 33.51% 306.83% -
Equity
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Net Worth 13,562,613 14,113,379 13,218,384 13,287,229 13,424,922 13,631,459 13,631,459 -0.33%
NOSH 6,884,575 6,884,575 6,884,575 6,884,575 6,884,575 6,884,575 6,884,575 0.00%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 8.86% 5.60% 2.83% -0.39% 1.04% 3.88% 3.85% -
ROE 6.76% 5.38% 3.09% 0.66% 1.95% 2.53% 2.55% -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 186.18 180.94 175.99 175.44 177.29 180.46 183.50 0.96%
EPS 13.32 11.02 5.93 1.28 3.81 5.01 5.05 90.56%
DPS 4.02 4.02 0.00 0.00 1.70 1.70 15.70 -59.57%
NAPS 1.97 2.05 1.92 1.93 1.95 1.98 1.98 -0.33%
Adjusted Per Share Value based on latest NOSH - 6,884,575
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 185.35 180.13 175.20 174.65 176.50 179.65 182.67 0.97%
EPS 13.26 10.98 5.90 1.27 3.79 4.99 5.03 90.49%
DPS 4.00 4.00 0.00 0.00 1.67 1.67 15.44 -59.26%
NAPS 1.9611 2.0408 1.9114 1.9213 1.9412 1.9711 1.9711 -0.33%
Price Multiplier on Financial Quarter End Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 -
Price 5.05 4.92 4.94 5.45 4.73 4.92 5.02 -
P/RPS 2.71 2.72 2.81 3.11 2.67 2.73 2.74 -0.72%
P/EPS 37.91 44.63 83.36 426.37 124.29 98.18 99.31 -47.28%
EY 2.64 2.24 1.20 0.23 0.80 1.02 1.01 89.42%
DY 0.80 0.82 0.00 0.00 0.36 0.35 3.13 -59.62%
P/NAPS 2.56 2.40 2.57 2.82 2.43 2.48 2.54 0.52%
Price Multiplier on Announcement Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 23/11/20 27/08/20 22/05/20 28/02/20 29/11/19 30/08/19 31/05/19 -
Price 5.17 5.16 4.92 4.96 4.98 4.98 4.66 -
P/RPS 2.78 2.85 2.80 2.83 2.81 2.76 2.54 6.18%
P/EPS 38.81 46.80 83.02 388.04 130.86 99.38 92.19 -43.74%
EY 2.58 2.14 1.20 0.26 0.76 1.01 1.08 78.41%
DY 0.78 0.78 0.00 0.00 0.34 0.34 3.37 -62.20%
P/NAPS 2.62 2.52 2.56 2.57 2.55 2.52 2.35 7.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment